Company Filing History:
Years Active: 1998
Title: Hsiao-Sheng Lieu: Innovator in Hepatoma Treatment
Introduction
Hsiao-Sheng Lieu is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of medical research, particularly in the treatment of hepatoma, a type of liver cancer. His innovative work has led to the development of novel compounds that show promise in combating this serious disease.
Latest Patents
Hsiao-Sheng Lieu holds a patent for "Compounds for the treatment of hepatoma." This patent describes compounds of general Formula I, where the substituents of R.sub.1 -R.sub.7 can include hydrogen, hydroxy groups, C.sub.1-6 alkyl groups, C.sub.1-6 alkoxy groups, or epoxypropoxy. Importantly, at most six of these substituents can simultaneously be hydrogen, methoxy groups, hydroxy groups, or epoxypropoxy groups, which are essential for their activity against hepatoma. The patent also outlines processes for preparing these novel compounds and useful intermediates, including substituted benzophenones. Hsiao-Sheng Lieu has 1 patent to his name.
Career Highlights
Hsiao-Sheng Lieu is affiliated with the National Science Council, where he conducts his research and development activities. His work is characterized by a strong focus on innovative solutions to complex medical challenges, particularly in oncology.
Collaborations
He has collaborated with notable colleagues, including Chun-Nan Lin and Shen-Jeu Won, to advance research in his field. Their combined efforts have contributed to the development of effective treatments for hepatoma.
Conclusion
Hsiao-Sheng Lieu's contributions to the treatment of hepatoma through his innovative compounds and collaborative research efforts highlight his importance in the field of medical science. His work continues to pave the way for advancements in cancer treatment.